Pliva owes the bulk of its financial success to regular income from the sale of azithromycin to the American pharmaceutical giant Pfizer, which sells its own brand of Sumamed under the name Zithromax.
Pliva duguje veliki deo svog finansijskog uspeha redovnim prihodima od prodaje azitromicina američkom finansijskom gigantu Fajzer, koji prodaje sopstvenu vrstu Sumameda pod nazivom Zitromaks.